Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
IGM Biosciences is a biotechnology company that develops medicine for people with infectious infections, autoimmune diseases, and cancer.
Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.
Mereo is a new UK-based speciality biopharmaceutical company.
SonoThera develops ultrasound-based technologies for delivering genetic therapies to targeted tissues.
Signadori Bio is the next-generation cellular immunotherapy for cancer cure.
ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.
Icosavax is focused on developing safe and effective vaccines against infectious diseases that address important unmet medical needs.
Whitehawk Therapeutics, a clinical-stage oncology therapeutics firm, applies cutting-edge technologies to well-established tumor biology.
Valneva focuses on the development and commercialization of prophylactic vaccines for infectious diseases.
Bonum Therapeutics creates a technology platform to treat a wide range of diseases.
Trevi Therapeutics is a clinical-stage biopharmaceutical company that develops drugs for treating uremic pruritus.
Revolution Medicines is an innovative and dynamic organization of expert biologists, chemists, pharmacologists, clinical scientists.
Ossium Health builds a bone marrow bank to treat blood cancers.
Zenas BioPharma is a biopharmaceutical company that focuses on developing immune-based therapies for patients.
OnKure is a clinical-stage biopharma company developing precision medicines targeting validated cancer drivers.
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
Candid Therapeutics develops therapies for autoimmune diseases using antibody-based technologies that modulate immune system activity.
Clasp Therapeutics offers to reach of immuno-oncology with novel precision medicines that enable the immune system.
SAB Biotherapeutics is a clinical-stage biopharmaceutical development company.
Aerobiotix is a privately held company specializing in the development and manufacture of proprietary environmental management devices.
Unicycive Therapeutics provides development programs that focus on treating kidney diseases with unmet medical needs.
Tarsus Pharmaceuticals is a clinical-stage biopharmaceutical company that develops treatments for diseases with high unmet need.
ASLAN Pharmaceuticals is an oncology-focused biotechnology company developing a portfolio of immuno-oncology agents and targeted therapies.
Arcutis Biotherapeutics is a clinical-stage biopharmaceutical company focused on developing medical dermatology for unmet needs.
Vivo Capital has invested in 167 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Vivo Capital's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 17 different industry categories.
Among tracked funding rounds, Revolution Medicines received $1.5B in a Post-IPO Equity round. Vivo Capital's total known invested capital is $18.9B.
Vivo Capital's average investment size is $138.0M across its portfolio of 167 companies.
Recent Vivo Capital portfolio additions include IGM Biosciences, Legend Biotech, Mereo Biopharma, SonoThera, Signadori Bio. These companies were founded in 2020 or later.